Survival advantage and clinicopathological significance of microRNA-22 in cancers: a meta-analysis
Qingming Xiang,1,* Zhenxian Xiang,2,* Rongzhang Dou,2 Bin Xiong2 1Department of Radiation and Medical Oncology, Zhongnan Hospital of Wuhan University, Hubei Key Laboratory of Tumor Biological Behaviors & Hubei Cancer Clinical Study Center, Wuhan 430071, People’s Republic of China;...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2019-10-01
|
| Series: | Cancer Management and Research |
| Subjects: | |
| Online Access: | https://www.dovepress.com/survival-advantage-and-clinicopathological-significance-of-microrna-22-peer-reviewed-article-CMAR |